KIAA0947_BC018507 Activators
KIAA0947 Activators represent a spectrum of chemical compounds that indirectly stimulate the functional activity of KIAA0947 by targeting various cellular signaling pathways. Compounds such as Forskolin, Dibutyryl-cAMP (db-cAMP), and 8-Bromo-cAMP are known to elevate intracellular cAMP, thereby activating cAMP-dependent protein kinase A (PKA). This activation can enhance KIAA0947's activity, as PKA signaling pathways are pivotal in numerous cellular processes. Similarly, Calyculin A and Okadaic Acid, which inhibit protein phosphatases, could sustain protein phosphorylation states that indirectly lead to an increase in KIAA0947 activity. Ionomycin, by increasing intracellular calcium levels, and Thapsigargin, by inhibiting Ca2+ ATPase and thereby also increasing intracellular calcium, can both impact calcium-dependent signaling pathways, potentially augmenting the activity of KIAA0947. Phorbol 12-myristate 13-acetate (PMA) and Bisindolylmaleimide I modulate PKC activity, with PMA activating and Bisindolylmaleimide I inhibiting PKC, both of which could result in alterations in phosphorylation patterns that influence KIAA0947 activity.
Additional molecules such as Insulin and Epidermal Growth Factor (EGF) activate pathways like PI3K/Akt and MAPK,which are crucial for cellular growth, metabolism, and proliferation, and these pathways could indirectly lead to the enhancement of KIAA0947 activity. Insulin's effect on the PI3K/Akt pathway, in particular, may have downstream effects that result in increased functional activity of KIAA0947. EGF, through its activation of the EGFR tyrosine kinase, triggers a cascade that can also modulate the activity of KIAA0947 by influencing cellular signaling related to proliferation. Sphingosine-1-phosphate (S1P) is another notable activator, exerting its effects through G-protein coupled receptor signaling, which may lead to enhanced KIAA0947 activity by affecting survival and proliferation pathways. The collective action of these activators, through their targeted modulation of key intracellular signaling pathways, serves to indirectly enhance the functional activity of KIAA0947, emphasizing the intricate network of cellular signaling in which KIAA0947 is potentially involved.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a diacylglycerol analog, activating protein kinase C (PKC), which can phosphorylate substrates that modulate various signaling pathways. PKC activation can lead to enhanced KIAA0947 activity through phosphorylation of associated proteins or modulation of signaling networks impacting KIAA0947. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calcium-dependent protein kinases, potentially enhancing the phosphorylation state and activity of KIAA0947 or its interacting partners within the cell. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases intracellular cAMP levels, similarly to Forskolin. The upregulation of cAMP may enhance the activity of KIAA0947 by activating PKA, which could target KIAA0947 or its associated proteins. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. Activation of PKA can lead to the modulation of KIAA0947 activity through phosphorylation or by affecting the signaling pathways that KIAA0947 is part of. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit certain protein kinases, potentially altering signaling pathways. This inhibition can indirectly enhance the activity of KIAA0947 by affecting signaling cascades or protein interactions that regulate KIAA0947 function. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin acts as a protein synthesis inhibitor and can activate stress-activated protein kinases (SAPKs). Activation of SAPKs could enhance KIAA0947 activity by influencing signaling pathways and cellular stress responses where KIAA0947 may play a role. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is another cell-permeable cAMP analog that activates PKA. The activation of PKA can lead to modifications of KIAA0947 or its related pathways, thus enhancing KIAA0947 function. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) pump inhibitor leading to increased cytosolic calcium levels. The change in calcium homeostasis can activate signaling pathways that enhance the activity of KIAA0947. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore like Ionomycin, raising intracellular calcium levels and potentially activating calcium-dependent kinases that may modulate KIAA0947 activity or the activity of proteins that interact with KIAA0947. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, and by inhibiting PI3K, it can modulate downstream signaling pathways. This can indirectly lead to enhanced KIAA0947 activity by affecting the balance of signaling pathways that KIAA0947 is involved in. | ||||||